Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Pasithea Therapeutics Announces In Vivo Preclinical Efficacy Data For PAS-004 From NRAS Mutation Cancer Xenograft Models; Says Once Daily Dose Of PAS-004 Delivers Anti-Tumor Efficacy In In Vivo NRAS Mutation Cancer Models

Author: Benzinga Newsdesk | December 11, 2023 09:03am

Posted In: KTTA